Literature DB >> 24833096

Epithelial-mesenchymal transition: molecular pathways of hepatitis viruses-induced hepatocellular carcinoma progression.

Concetta Panebianco1, Chiara Saracino, Valerio Pazienza.   

Abstract

Hepatocellular carcinoma is the fifth most common tumor and the third cause of death for cancer in the world. Among the main causative agents of this tumor is the chronic infection by hepatitis viruses B and C, which establish a context of chronic inflammation degenerating in fibrosis, cirrhosis, and, finally, cancer. Recent findings, however, indicate that hepatitis viruses are not only responsible for cancer onset but also for its progression towards metastasis. Indeed, they are able to promote epithelial-mesenchymal transition, a process of cellular reprogramming underlying tumor spread. In this manuscript, we review the currently known molecular mechanisms by which hepatitis viruses induce epithelial-mesenchymal transition and, thus, hepatocellular carcinoma progression.

Entities:  

Mesh:

Year:  2014        PMID: 24833096     DOI: 10.1007/s13277-014-2075-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  111 in total

Review 1.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

2.  Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update.

Authors:  Angela Gauthier; Mitchell Ho
Journal:  Hepatol Res       Date:  2012-11-12       Impact factor: 4.288

Review 3.  TGF-beta signaling in cancer--a double-edged sword.

Authors:  R J Akhurst; R Derynck
Journal:  Trends Cell Biol       Date:  2001-11       Impact factor: 20.808

4.  Tumor-derived secretory clusterin induces epithelial-mesenchymal transition and facilitates hepatocellular carcinoma metastasis.

Authors:  Cun Wang; Kai Jiang; Xiaonan Kang; Dongmei Gao; Chun Sun; Yan Li; Lu Sun; Shu Zhang; Xiaohui Liu; Weizhong Wu; Pengyuan Yang; Kun Guo; Yinkun Liu
Journal:  Int J Biochem Cell Biol       Date:  2012-09-23       Impact factor: 5.085

Review 5.  Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms.

Authors:  Christian Bréchot
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

Review 6.  Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation.

Authors:  Dianbo Yao; Chaoliu Dai; Songlin Peng
Journal:  Mol Cancer Res       Date:  2011-08-12       Impact factor: 5.852

7.  Sorafenib in advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245

8.  Hepatitis B virus X protein promotes hepatoma cell invasion and metastasis by stabilizing Snail protein.

Authors:  Haiou Liu; Le Xu; Hongyong He; Yu Zhu; Jing Liu; Shanshan Wang; Lin Chen; Qian Wu; Jiejie Xu; Jianxin Gu
Journal:  Cancer Sci       Date:  2012-10-18       Impact factor: 6.716

9.  HBx protein induces EMT through c-Src activation in SMMC-7721 hepatoma cell line.

Authors:  Shi Zhong Yang; Lei Da Zhang; Yi Zhang; Yan Xiong; Yu Jun Zhang; Hao Lin Li; Xiao Wu Li; Jia Hong Dong
Journal:  Biochem Biophys Res Commun       Date:  2009-03-18       Impact factor: 3.575

10.  Hepatitis delta virus RNA replication.

Authors:  Chung-Hsin Tseng; Michael M C Lai
Journal:  Viruses       Date:  2009-11-06       Impact factor: 5.048

View more
  6 in total

Review 1.  Hepatitis viruses exploitation of host DNA methyltransferases functions.

Authors:  Valerio Pazienza; Concetta Panebianco; Angelo Andriulli
Journal:  Clin Exp Med       Date:  2015-07-07       Impact factor: 3.984

2.  JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells.

Authors:  Bo Tang; Guangying Qi; Fang Tang; Shengguang Yuan; Zhenran Wang; Xingsi Liang; Bo Li; Shuiping Yu; Jie Liu; Qi Huang; Yangchao Wei; Run Zhai; Biao Lei; Hongping Yu; Xingyuan Jiao; Songqing He
Journal:  Oncotarget       Date:  2015-05-20

3.  Hepatitis B virus X protein promotes interleukin-7 receptor expression via NF-κB and Notch1 pathway to facilitate proliferation and migration of hepatitis B virus-related hepatoma cells.

Authors:  Fanyun Kong; Wei Hu; Kai Zhou; Xiao Wei; Yanbo Kou; Hongjuan You; Kuiyang Zheng; Renxian Tang
Journal:  J Exp Clin Cancer Res       Date:  2016-11-07

Review 4.  Role of hypoxia-induced exosomes in tumor biology.

Authors:  Chuchu Shao; Fengming Yang; Suyu Miao; Weitao Liu; Chaoshan Wang; Yongqian Shu; Hua Shen
Journal:  Mol Cancer       Date:  2018-08-11       Impact factor: 27.401

5.  Hepatitis C virus NS4B protein induces epithelial-mesenchymal transition by upregulation of Snail.

Authors:  Bicheng Hu; Shenggao Xie; Yuqian Hu; Wen Chen; Xiaofan Chen; Yi Zheng; Xinxing Wu
Journal:  Virol J       Date:  2017-04-21       Impact factor: 4.099

6.  Investigation of the role of cullin 4A overexpression in human liver cancer.

Authors:  Gang Chen; Xiongqi Zhao; Zedan Tan; Dongdong Wang; Ding Luo; Peiyao Zhang; Jun Cao; Fan Wang; Qiyu Liu; Li Li
Journal:  Mol Med Rep       Date:  2018-06-29       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.